| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/03/2002 | CA2413552A1 Alkyl ether modified polycyclic compounds having a terminal phenol as cell protecting agents |
| 01/03/2002 | CA2413545A1 Methods and compositions for treating pain of the mucous membrane |
| 01/03/2002 | CA2413417A1 Selective androgen receptor modulators and methods for their identification, design and use |
| 01/03/2002 | CA2413405A1 Enhanced brain function by gaba-ergic stimulation |
| 01/03/2002 | CA2413338A1 Protein mixtures for wound healing |
| 01/03/2002 | CA2413336A1 Synthesis of cyclic compounds |
| 01/03/2002 | CA2413330A1 Wet milling process |
| 01/03/2002 | CA2413201A1 Treatment for cardiovascular disease |
| 01/03/2002 | CA2413157A1 Biodegradable vehicles and delivery systems of biologically active substances |
| 01/03/2002 | CA2413143A1 A synthetic bulk laxative |
| 01/03/2002 | CA2412640A1 Iminopyrimidine nmda nr2b receptor antagonists |
| 01/03/2002 | CA2412612A1 Eg-vegf nucleic acids and polypeptides and methods of use |
| 01/03/2002 | CA2412592A1 Substituted quinazoline derivatives and their use as inhibitors |
| 01/03/2002 | CA2412568A1 Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates |
| 01/03/2002 | CA2412563A1 Melanocortin receptor ligands |
| 01/03/2002 | CA2412559A1 Polycyclic xanthones as antibiotics |
| 01/03/2002 | CA2412555A1 Fused azepine derivatives and their use as antidiuretic agents |
| 01/03/2002 | CA2412535A1 Polymorphic forms/hydrates of n-[4-(3-chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)-quinazolin-6-yl]-acrylamide dihydrochloride |
| 01/03/2002 | CA2412490A1 Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition |
| 01/03/2002 | CA2412024A1 Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates |
| 01/03/2002 | CA2411714A1 Novel cephalosporin compounds and process for preparing the same |
| 01/03/2002 | CA2411552A1 Glucagon antagonists/inverse agonists |
| 01/03/2002 | CA2411545A1 Tripeptide prodrug compounds |
| 01/03/2002 | CA2411167A1 Polynucleotide vaccine adjuvants and formulations containing cationic surfactants, and methods of use |
| 01/03/2002 | CA2411162A1 Compounds useful for the preparation of medicaments with phosphodiesterase iv inhibitory activity |
| 01/03/2002 | CA2411157A1 Benzodiazepines as inhibitors of hpv e1 helicase |
| 01/03/2002 | CA2410393A1 1 - (heteroaryl-phenyl) - condensed pyrazol derivatives as factor xa inhibitors |
| 01/03/2002 | CA2409762A1 Heteroaryl-phenyl substituted factor xa inhibitors |
| 01/03/2002 | CA2409408A1 Modulation of chromosome function by chromatin remodeling agents |
| 01/02/2002 | WO2002098412A1 Pharmaceutical composition comprising a lipase inhibitor and a sucrose fatty acid ester |
| 01/02/2002 | WO2002096394A2 Pharmaceutical composition containing stool softener such as polaxamer and enteric coated particles of bisacodyl |
| 01/02/2002 | EP1167972A2 Enzyme catalyzed therapeutic agents |
| 01/02/2002 | EP1167379A2 Immunomodulatory oligonucleotides |
| 01/02/2002 | EP1167378A2 Immunomodulatory oligonucleotides |
| 01/02/2002 | EP1167377A2 Immunomodulatory oligonucleotides |
| 01/02/2002 | EP1167376A1 Macrolide antibiotics |
| 01/02/2002 | EP1167374A1 Glycosphingolipid |
| 01/02/2002 | EP1167369A1 Novel thiazolobenzimidazole derivatives |
| 01/02/2002 | EP1167366A1 Amine derivatives |
| 01/02/2002 | EP1167364A1 Benzopyran-containing compounds and prodrug forms thereof |
| 01/02/2002 | EP1167363A2 Novel crystalline forms of (3S-trans)-2-(3,4-dihydro-4-hydroxy-3-(phenylmethyl)-2H-1-benzopyran-7-yl)-4-(trifluoromethyl)-benzoic acid |
| 01/02/2002 | EP1167360A1 Human chymase inhibitors |
| 01/02/2002 | EP1167357A1 Alpha-substituted carboxylic acid derivatives |
| 01/02/2002 | EP1167341A1 Substituted nitrated catechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them |
| 01/02/2002 | EP1166811A2 Metered dose inhaler for fluticasone propionate |
| 01/02/2002 | EP1166801A1 Preparations containing silicon dioxide to improve the taste thereof |
| 01/02/2002 | EP1166800A1 Pharmaceutical compositions containing antibiotics and fructan mixtures |
| 01/02/2002 | EP1166794A2 Method of treating retained pulmonary secretions |
| 01/02/2002 | EP1166792A2 Extracts, compounds & pharmaceutical compositions having anti-diabetic activity and their use |
| 01/02/2002 | EP1166791A2 Antipsoriatic compositions comprising an asphodelus extract, method of making, and method of using |
| 01/02/2002 | EP1166788A1 Remedies for joint diseases |
| 01/02/2002 | EP1166787A2 Stable amino acid based bicarbonate solutions for peritoneal dialysis and hemodialysis |
| 01/02/2002 | EP1166786A1 Medicinal compositions |
| 01/02/2002 | EP1166785A1 Use of pyrazole derivatives for inhibiting thrombin-induced platelet aggregation |
| 01/02/2002 | EP1166784A1 Inhibitors for vascular reconstriction after angioplasty |
| 01/02/2002 | EP1166783A2 Tetrahydrobenz[CD]indole-6-carboxamides for treating sexual dysfunction |
| 01/02/2002 | EP1166782A2 Anti-retroviral pharmaceutical compositions |
| 01/02/2002 | EP1166780A2 Use of physiologically acceptable sulfinic acid as antioxidant or radical scavenger in cosmetic or dermatologic preparations |
| 01/02/2002 | EP1166779A2 The use of nimesulide in the treatment of dermatological diseases |
| 01/02/2002 | EP1166778A2 The use of growth hormone scretagogues to treat systemic lupus erythematosus and inflammatory bowel disease |
| 01/02/2002 | EP1166773A1 Solution of N- O(p-pivaloyloxbenzenesulfonylamino)benzoyl glycine monosodium salt tetra-hydrate and drug product thereof |
| 01/02/2002 | EP1166768A1 Use of ergothioneine and its derivatives as a glycation inhibitor |
| 01/02/2002 | EP1166766A1 External preparation compositions |
| 01/02/2002 | EP1166765A2 Process for protecting human skin |
| 01/02/2002 | EP1166760A1 Method of promoting skin cell metabolism |
| 01/02/2002 | EP1166653A2 Iron-containing protein composition |
| 01/02/2002 | EP1166652A1 Utilization of material containing docosapentaenoic acid |
| 01/02/2002 | EP1166651A1 Synthetic sweetener |
| 01/02/2002 | EP1165828A1 50 human secreted proteins |
| 01/02/2002 | EP1165827A1 45 human secreted proteins |
| 01/02/2002 | EP1165795A2 Streptococcus pneumoniae antigens |
| 01/02/2002 | EP1165785A1 48 human secreted proteins |
| 01/02/2002 | EP1165784A2 Nucleic acids including open reading frames encoding polypeptides; "orfx" |
| 01/02/2002 | EP1165774A2 Casb619 involved in colon cancers |
| 01/02/2002 | EP1165770A2 Methods for the identification and validation of functional intracellular targets with intramers or in vivo selection |
| 01/02/2002 | EP1165758A2 Regulation of the expression of transcriptional repressor genes using nucleic acid molecules |
| 01/02/2002 | EP1165620A1 INCLUSION COMPLEXES OF POLYUNSATURATED FATTY ACIDS AND THEIR DERIVATIVES WITH $g(g)-CYCLODEXTRIN |
| 01/02/2002 | EP1165605A1 Androgen-induced suppressor of cell proliferation and uses thereof |
| 01/02/2002 | EP1165602A1 49 human secreted proteins |
| 01/02/2002 | EP1165600A1 Proteins modified by xanthurenic acid |
| 01/02/2002 | EP1165596A1 14,15-.alpha.-methylene equilenine derivatives, methods for producing the same and medicaments containing them |
| 01/02/2002 | EP1165595A1 Liver specific bile acid derivatives of the glucocorticoid antagonist ru486 |
| 01/02/2002 | EP1165594A1 Antisense oligonucleotide modulation of stat3 expression |
| 01/02/2002 | EP1165593A1 ANTISENSE MODULATION OF p38 MITOGEN ACTIVATED PROTEIN KINASE EXPRESSION |
| 01/02/2002 | EP1165587A1 50 human secreted proteins |
| 01/02/2002 | EP1165586A1 TCL-1b GENE AND PROTEIN AND RELATED METHODS AND COMPOSITIONS |
| 01/02/2002 | EP1165576A1 Process for preparing amine platinum complexes |
| 01/02/2002 | EP1165575A1 Phosphate containing macrocyclic immunomodulators |
| 01/02/2002 | EP1165570A2 Novel phosphorus-containing prodrugs |
| 01/02/2002 | EP1165567A2 Sulfamate containing macrocyclic immunomodulators |
| 01/02/2002 | EP1165566A1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 01/02/2002 | EP1165565A1 Optically pure camptothecin analogues |
| 01/02/2002 | EP1165564A2 Process for preparing inhibitors of nucleoside metabolism |
| 01/02/2002 | EP1165563A1 Bicyclic heterocycles, method for producing them and their use as herbicides and pharmaceutical agents |
| 01/02/2002 | EP1165562A1 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 01/02/2002 | EP1165561A1 6-substituted biaryl purine derivatives as potent cyclin/cdk inhibitors and antiproliferative agents |
| 01/02/2002 | EP1165560A1 2-hydroxy methylcyclopro pylidenemethyl purines and -pyrimidines as antiviral agents |
| 01/02/2002 | EP1165559A1 1,4-diazabicyclo 3.2.2]nonane-4-carboxylate and carboxamide derivatives, production and use thereof in therapeutics |
| 01/02/2002 | EP1165558A1 Derivatives of pyrimido[6,1-a]isoquinolin-4-one |
| 01/02/2002 | EP1165557A1 ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS |